intravitreous

in·tra·vit·re·ous

(in'tră-vit'rē-ŭs),
Within the vitreous body.

intravitreal

, intravitreous (in″tră-vi′trē-ăl) (in″tră-vi′trē-ŭs) [ intra- + L. vitreus, glassy]
Within the vitreous body of the eye.
References in periodicals archive ?
STATION Robot prepares liquid and powder medications in syringes and IV Bags for biologic, antifungal, intravitreous, and antibiotic drugs, which where formerly prepared in laminar airflow hoods in the Pharmacy, or the case of antibiotics at some of the wards or nurse stations throughout the hospital.
She was treated with intravitreous gancyclovir, and ART (lamivudine, tenofovir and nevirapine) was started in November 2010.
Two phase 3 clinical trials demonstrated that a single intravitreous injection of ovine hyaluronidase was not associated with any serious safety issues and hyaluronidase had some therapeutic utility in the management of vitreous hemorrhage.
This need has led to the development of drug products such as Macugen and Lucentis, which are administered by direct intravitreous delivery to the target tissues--the retina and choroid.
Effect of intravitreous rituximab injections in patients with recurrent ocular lesions associated with central nervous system lymphoma.
Intravitreous injections of pegaptanib, an agent that blocks the activity of vascular endothelial growth factor, arrests the loss of visual acuity in patients with age-related macular degeneration due to choroidal neovascularization, according to Evangelos S.
Glymbia, Alexander Kennedy and Gary Abrams of Wayne State University, Kresge Eye Institute in Detroit and Raymond Iezzi of the Mayo Clinic in Rochester, used pSivida's Durasert technology to study the neuroprotective properties of low-dose sustained-release intravitreous FA as a means of reducing retinal neuroinflammation, preventing cell death and preserving retinal function.
In particular, this session will discuss the evidence for intravitreous aflibercept which has the potential to offer new treatment options for patients with RVO.
The lowest dose of pegaptanib, administered every 6 weeks by intravitreous injection, significantly increased the number of patients who maintained their vision compared with controls given sham injections, said Dr.
et al, Acute Intraocular Inflammation after Intravitreous Injections of Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration Ophthalmology 2008;115:1911-1915
Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema.